Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Live attenuated Listeria monocytogenes delta actA/delta inlB strain expressing human mesothelin

EU orphan designation number: EU/3/15/1594   
Active ingredient: Live attenuated Listeria monocytogenes delta actA/delta inlB strain expressing human mesothelin
Indication: Treatment of malignant mesothelioma
Sponsor: Aduro Biotech Holdings, Europe B.V.
Pivot Park RX 1101, Molenweg 79, 5349 AC Oss, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/12/2015 Orphan designation EMA/OD/157/15 (2015)9516 of 14/12/2015
15/04/2016 Transfer of orphan designation EMA/OD/157/15/T/01 (2016)2262 of 13/04/2016